Gut bacteria | Source of MSC | Experimental condition | Pathways/secretomes involved | Outcome of interaction | References |
---|---|---|---|---|---|
Specific-pathogen-free (SPF) gut microbiota | Bone marrow | DSS-induced colitis | Cell metabolic, HIF-1/inflammatory signaling, and neurodegenerative pathways | Altered MSC differentiation potential Enhanced immunomodulation capacity of MSC Decreased disease activity index | [67] |
Lactobacillus acidophilus | Canine adipose | In vitro | Increased transcription of key immunomodulatory genes, like COX2, IL6 and IL8 Significantly increased PGE2 | Enhanced immunoregulatory function No induction of MSC death, degeneration or diminished proliferation No effect on MSC migration | [70] |
Salmonella typhi | Canine adipose | In vitro | Increased transcription of key immunomodulatory genes like COX2, IL6 and IL8 | No induction of antigen-presenting phenotype Increased capacity of MSCs to inhibit mitogen-induced T-cell proliferation Induction and expression of PPARγ, IL-6, IL8, HGF, COX2, CD54 and PGE2 Impeded MSC migration | [70] |
Restored composition and diversity of gut microbiota with Lactobacillus | Bone marrow | Chronic hypoxic rats | – | Restored defect of senescence, poor cell proliferation, cell cycle arrest and multi-lineage differentiation deficiency in MSCs Reduced d-galactose accumulation | [47] |
Lactobacillus rhamnosus GG | Lamina propria of the villus | Intestinal radioprotection in vitro | TLR2 and COX-2 dependent induction | Lactobacillus rhamnosus GG produced LTA, which then primed the epithelial stem cell niche to protect epithelial stem cells by activating macrophages and PGE2 secreting MSCs | [76] |
Helicobacter pylori | Bone marrow | GIT infection by H. pylori | Over-expression of TNFα and CCL2 TNFα leads to activation of NF-κB-dependent pathway | Stimulated migration of MSC | [77] |